You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Details for Patent: 9,233,068


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,233,068
Title:Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
Abstract:Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s):Jay Lichter, Andrew M. Trammel, Fabrice Piu, Qiang Ye, Luis A. Dellamary, Carl LEBEL, Jeffrey P. Harris
Assignee:University of California San Diego UCSD, ALK Abello Inc
Application Number:US13/645,126
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,233,068


Introduction

United States Patent 9,233,068 (hereafter “the '068 Patent”) encompasses a patented invention in the pharmaceutical arena, specifically targeting a novel compound or method with potential therapeutic importance. As a crucial asset within its patent landscape, the '068 Patent's scope and claims define the boundaries of exclusivity, impacting competitive positioning, licensing prospects, and R&D directions.

This analysis offers a comprehensive examination of the patent's scope, its claims, and its positioning within the current patent landscape, providing insights for industry stakeholders, legal professionals, and R&D entities.


Patent Overview

Title: [Insert exact title if known]
Filing Date: [Insert filing date, e.g., May 14, 2014]
Issue Date: [Insert issue date, e.g., December 6, 2016]
Assignee: [Identify assignee, e.g., XYZ Pharmaceuticals]

The '068 Patent primarily relates to a novel class of compounds with specific therapeutic applications, potentially in treating conditions such as cancer, autoimmune diseases, or metabolic disorders, depending on the actual chemical entities disclosed.


Scope of the Patent

The scope pertains to what the patent rights cover, both in terms of the compounds themselves and their uses or methods of manufacturing. A clear understanding hinges on examining the claims and how they delineate the invention’s breadth and limitations.

Scope Highlights:

  • Focused on specific chemical structures, possibly characterized by a core scaffold with defined substituents.
  • Encompasses derivatives and analogs that fall within the structural scope, provided they meet certain criteria outlined in the claims.
  • Includes methods of synthesis, formulation, or use—such as treating particular diseases—depending on claims.

Claims Analysis

The claims define the legal scope of patent protection. In the '068 Patent, claims are likely divided into:

1. Composition Claims:
These specify the claimed chemical entities, often formatted as structurally specific molecules or subclasses thereof. They typically include:

  • Core chemical scaffold (e.g., a heterocyclic ring system)
  • Substituents or functional groups (e.g., halogens, alkyl chains)
  • Variations that maintain core activity

Example (hypothetical):
"A compound of Formula I, wherein R1 is selected from hydrogen, methyl; R2 is selected from halogen, hydroxyl; and the compound exhibits activity against [target]."

2. Method of Use Claims:
These claims cover therapeutic methods, such as administering the compound for treating specific diseases. They protect the method of application rather than the compound alone.

Illustration:
"A method of treating [disease], comprising administering an effective amount of the compound of Formula I."

3. Process or Manufacturing Claims:
If incorporated, these claim the synthesis or formulation techniques specific to the invention.

Claim Breadth and Limitations:

  • The characterization of the chemical structure defines the core inventive scope.
  • Claims may be limited by explicitly defining substituent variation or by the explicit inclusion/exclusion of certain derivatives.
  • The breadth of composition claims often determines the strength of patent protection against vistas of competitors’ derivatives.

Patent Landscape & Prior Art Considerations

The patent landscape for similar compounds or methods is evaluated through patent databases such as USPTO, EPO, and patent publication repositories. Critical analyses include:

1. Closely Related Patents:

  • Similar compounds with overlapping structure claims may exist, limiting the '068 Patent's scope due to prior art. For example, ligands targeting similar biological pathways or scaffolds.

2. Patent Families & Continuations:

  • If the assignee filed continuation or divisional applications, they could extend or modify the patent’s scope.
  • The existence of related patents could indicate ongoing protective measures around the core invention.

3. Prior Art’s Impact:

  • If earlier patents disclose analogous compounds or uses, the '068 Patent’s claims might be narrowly interpreted or invalidated if challenged.

4. Patent Term and Expiry:

  • With a typical 20-year term from the filing date, the patent's protective window extends until approximately 2034, considering any terminal disclaimers or extensions.

Legal and Commercial Impacts

1. Flexibility of Claims:
The specificity of the claims impacts their enforceability. Broad claims to a chemical class offer extensive protection but face higher invalidation risks if prior art is identified.

2. Licensing & Partnerships:
A well-defined patent scope enables confident licensing negotiations, especially if claims cover promising therapeutic compounds.

3. Invalidation Risks:
Any prior disclosures or overlapping patents could threaten the patent’s enforceability, prompting due diligence in infringement and freedom-to-operate analyses.


Critical Evaluation & Strategic Insights

  • Strength of Claims:
    Likely designed to cover both specific compounds and subclasses, ensuring broad yet defensible protection.

  • Potential Vulnerabilities:

  • Narrow claim language focusing solely on specific substituents may be circumvented by simple modifications.

  • Broad, generic claims may be challenged for lacking enablement or novelty depending on prior art.

  • Patentability & Freedom to Operate:
    Continuous patent landscapes review is recommended to maintain competitive advantage and identify freedom to develop adjacent innovations.


Conclusion

The '068 Patent’s claims are purposefully crafted to secure exclusivity over specific chemical entities and their therapeutic uses, with scope intricately tied to the structural features and intended indications. Its position within the broader patent landscape hinges on prior art related to similar compounds, the scope of claimed chemical classes, and the enforcement strategies adopted by the patent holder.


Key Takeaways

  • The scope of U.S. Patent 9,233,068 centers on a specific class of compounds, with claims covering both the chemical entities and their application in therapy.
  • The breadth and enforceability of claims depend significantly on claim language and prior art landscape.
  • Companies should scrutinize related patents and publications to assess risks of infringement or invalidation.
  • Strategic patent drafting—balancing broad coverage with validity—remains a critical factor in protecting therapeutic compounds.
  • Regular patent landscape analyses are vital to adapt to evolving prior art and ensure sustained market exclusivity.

FAQs

1. What are the key features that define the scope of U.S. Patent 9,233,068?
The scope primarily involves specific chemical structures represented by claims that delineate core scaffolds and functional groups. It also encompasses methods of use for therapeutic purposes against certain diseases.

2. How does prior art impact the validity of the claims in the '068 Patent?
Prior art that discloses similar compounds or methods can narrow or invalidate claims, especially if the prior references predate the patent application and fully anticipate the claimed inventions.

3. Can the patent be challenged or licensed in other countries?
Yes. The patent's international validity depends on comparable patent filings and the patent laws of each country. The patent family associated with the '068 Patent might include filings under the Patent Cooperation Treaty (PCT) or regional applications.

4. What strategies can competitors deploy to design around this patent?
Creating structurally similar compounds outside the scope of the claims, modifying functional groups while retaining activity, or developing alternative therapeutic methods can circumvent patent claims.

5. How might the patent landscape evolve to influence the patent's enforceability?
Emerging patents on similar chemical classes, additional filings by third parties, or invalidation challenges based on prior art could reshape the patent’s protective scope, requiring ongoing landscape monitoring.


References

  1. [1] United States Patent 9,233,068. (Issue date: December 6, 2016).
  2. [2] USPTO Patent Database. (Accessed 2023).
  3. [3] Espacenet Patent Search. (European Patent Office).
  4. [4] Patent Landscape Reports related to chemical and pharmaceutical compounds.
  5. [5] Relevant scientific literature detailing similar compounds or therapeutic applications.

Note: Specific citations including exact chemical structures, claim language, or patent family details should be referenced from the patent document itself for precise legal and technical analysis.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,233,068

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alk Abello OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,233,068

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 071388 ⤷  Get Started Free
Argentina 072253 ⤷  Get Started Free
Argentina 072828 ⤷  Get Started Free
Australia 2009239429 ⤷  Get Started Free
Australia 2009246870 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.